Free Trial

This company has been marked as potentially delisted and may not be actively trading.

HeartBeam (BEAT) Competitors

HeartBeam logo

BEAT vs. KRMD, AMWL, EUDA, LUNG, MDXH, CCLD, YI, IPA, PIII, and ZEPP

Should you be buying HeartBeam stock or one of its competitors? The main competitors of HeartBeam include KORU Medical Systems (KRMD), American Well (AMWL), EUDA Health (EUDA), Pulmonx (LUNG), MDxHealth (MDXH), CareCloud (CCLD), 111 (YI), ImmunoPrecise Antibodies (IPA), P3 Health Partners (PIII), and Zepp Health (ZEPP). These companies are all part of the "medical info sys" industry.

HeartBeam vs. Its Competitors

KORU Medical Systems (NASDAQ:KRMD) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

KORU Medical Systems currently has a consensus target price of $4.50, indicating a potential upside of 20.00%. HeartBeam has a consensus target price of $8.00, indicating a potential upside of 517.76%. Given HeartBeam's higher probable upside, analysts plainly believe HeartBeam is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
HeartBeam
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

HeartBeam has a net margin of 0.00% compared to KORU Medical Systems' net margin of -15.09%. KORU Medical Systems' return on equity of -30.43% beat HeartBeam's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-15.09% -30.43% -19.41%
HeartBeam N/A -358.33%-278.76%

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 0.00 equaled HeartBeam'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
HeartBeam
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems has higher revenue and earnings than HeartBeam. KORU Medical Systems is trading at a lower price-to-earnings ratio than HeartBeam, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$33.65M5.14-$6.07M-$0.11-34.09
HeartBeamN/AN/A-$19.45M-$0.68-1.90

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 7.8% of HeartBeam shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by company insiders. Comparatively, 18.0% of HeartBeam shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

KORU Medical Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, HeartBeam has a beta of -0.7, indicating that its stock price is 170% less volatile than the S&P 500.

Summary

KORU Medical Systems beats HeartBeam on 10 of the 12 factors compared between the two stocks.

Get HeartBeam News Delivered to You Automatically

Sign up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BEAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BEAT vs. The Competition

MetricHeartBeamMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$44.63M$1.98B$5.50B$8.96B
Dividend YieldN/AN/A5.25%4.02%
P/E RatioN/A16.6219.9019.84
Price / SalesN/A16.52436.90127.27
Price / CashN/A55.7437.0657.97
Price / Book21.588.588.125.62
Net Income-$19.45M-$62.39M$3.16B$248.50M

HeartBeam Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BEAT
HeartBeam
1.6145 of 5 stars
$1.30
-38.0%
$8.00
+517.8%
-50.7%$44.63MN/A0.001,700Gap Up
KRMD
KORU Medical Systems
1.5866 of 5 stars
$3.68
+2.8%
$4.50
+22.3%
+52.0%$169.80M$35.08M-33.4580High Trading Volume
AMWL
American Well
3.4863 of 5 stars
$8.47
-4.7%
$9.67
+14.1%
+33.1%$132.22M$254.36M-0.831,040
EUDA
EUDA Health
N/A$3.42
-4.5%
N/A-8.2%$127.09M$4.01M0.002
LUNG
Pulmonx
3.1283 of 5 stars
$2.69
+3.9%
$11.53
+328.4%
-57.7%$108.30M$83.79M-1.87250News Coverage
MDXH
MDxHealth
1.5617 of 5 stars
$2.12
-4.1%
$6.50
+206.6%
-23.2%$100.26M$90.05M-1.84300
CCLD
CareCloud
2.3114 of 5 stars
$2.27
-3.8%
$2.50
+10.1%
+19.8%$96.07M$110.84M-10.323,650
YI
111
0.6049 of 5 stars
$7.11
-0.4%
N/A-27.3%$61.43M$1.97B-11.111,238
IPA
ImmunoPrecise Antibodies
2.3332 of 5 stars
$1.09
+2.8%
$4.00
+267.0%
+76.0%$49.88M$18.16M-0.9480News Coverage
PIII
P3 Health Partners
2.8938 of 5 stars
$6.34
+0.6%
$16.25
+156.3%
-75.6%$45.59M$1.50B-0.13500Positive News
ZEPP
Zepp Health
3.1736 of 5 stars
$2.82
+6.1%
$13.87
+391.7%
+88.8%$40.90M$182.60M-0.561,230News Coverage

Related Companies and Tools


This page (NASDAQ:BEAT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners